Sanofi to cut insulin prices by 78% starting January 2024
Pharmafile
MARCH 17, 2023
French pharmaceutical company Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 units/ml by 78%, beginning January 2024. read more
Let's personalize your content